US EditionPublished • loading... • Updated
China Focus: China’s Leapfrog Progress from Generic to Innovative Drugs, Medical Equipment
Summary by iChongqing
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
China Focus: China’s Leapfrog Progress from Generic to Innovative Drugs, Medical Equipment
The domestically ARNI drug, Sacubitril Valsartan Calcium Tablets, is approved by National Medical Products Administration and in production. (Photo/Xinhua) Beijing - Beyond its well-known strengths in manufacturing, artificial intelligence and robotics, China is also carving out an edge in the sphere of pharmaceuticals. At a press conference on the country's progress in the health sector during the 14th Five-Year Plan period (2021-2025) on Thurs…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
